Dr. Hubert Zajicek is president of ASciNA. He also was a co-founder and long-time board member of ASciNA, serving in many different capacities. He is executive director, co-founder and partner at Health Wildcatters, a seed stage healthcare accelerator in Dallas. He previously was managing director - medical technology of NTEC (North Texas Enterprise Center) - Medical Technology in Dallas-Fort Worth, Texas and organizer of the regions' largest medical technology investment conference, MedVentures every year. Before joining NTEC he held a faculty position in the Department of Internal Medicine - Nephrology and Cell Biology at UT Southwestern, where he also was a post-doctoral NIH-fellow. Hubert received his Doctorate in Medicine (M.D.) from the University of Vienna, School of Medicine (1996), and his Master of Business Administration (M.B.A.) from the Cox School of Business at Southern Methodist University in 2006.
Franz Franchetti is Assistant Research Professor with the Department of Electrical and Computer Engineering at Carnegie Mellon University and CTO of SpiralGen, a CMU spin-off company commercializing the technology developed in the SPIRAL project. Dr. Franchetti's research focuses on automatic performance tuning and program generation for emerging parallel platforms, including embedded processors and mobile chipsets, multicore and manycore CPUs, clusters and high-performance systems, graphics processors, and field programmable gate arrays. He is chaper head of the Pennsylvania chapter and webmaster of ascina.at.
Jürgen Haberleithner is a Professor and Researcher at an APEC Studies Center (Official Research Center of APEC - Asia Pacific Economic Cooperation - member countries), at the University of Colima, Mexico. His profile is a hybrid between international academic and business development. He holds a PHD in International Affairs (Political Science), at the University of Vienna (Austria) and at the Austrian Institute for International Affairs. After several years of empirical research in Seville (Spain) he also obtained a PHD degree in Spain (Universidad Pablo de Olavide, Seville - Doctor of Philosophy). His main fields of research are socio-economics, Labor Market Policy and International Scientific Cooperation (e. g. FP7). Mr. Haberleithner is also working as a certified Coach in Latin America and Europe on Business Development, Intercultural Communication and Academic Coaching, and has more than 4000 hours of experience in group and individual settings. He is head of ASCINA Mexico, member of the board of the Austrian-Spanish Society and an active member of Triple Helix Association (Stanford University). His main working languages are German, English and Spanish.
Gerhard König studied Molecular Biology and Scientific Computing at the University of Vienna. After receiving his doctorate in Natural Sciences he became a Visiting Fellow at the NIH-NHLBI Laboratory of Computational Biology. His research focuses on the development of simulation-based methods to predict binding affinities of ligands to their receptors as well as the effect of point mutations in proteins.
Dr. Peter Nagele ist Immediate Past-President von ASCINA. Von 2008 bis 2011 bekleidete er das Amt des Präsidenten. Er arbeitet seit 2005 Anästhesist an der Washington University School of Medicine in St. Louis, USA, und leitet dort eine klinische Forschungsgruppe. Seine Forschung konzentriert sich auf Pharmakogenetik und perioperative Outcomes-Forschung. Er hat an der Uni Innsbruck Medizin studiert und seine Facharztausbildung in Anaesthesiologie und Intensivmedizin am AKH Wien abgeschlossen. 2005 habilitierte sich Peter Nagele an der Medizinischen Universität Wien und ist seither in den USA. Er ist Gründungsmitglied von ASCINA und leidenschaftlicher Österreicher.